Basma Adeem Medical Co. (9626)
Tadawul
5.89
+0.0100 (+0.17%)
Closed
Sep 20, 2026
Day's Range
5.885.91
52 wk Range
4.957.00
Financial Statements - 9626 - Basma Adeem Medical Co.
Revenue
45.45M▲ 34.0%
Net Income
7.30M▲ 15.9%Net Margin 16.1%
EBITDA
9.02M▲ 26.6%
Free Cash Flow
11.36M▲ 42.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 45.45M | 33.91M |
| Cost of Goods | 32.13M | 22.80M |
| Gross Profit | 13.31M | 11.11M |
 Operating Expense | - | - |
| Operating Income | 8.08M | 6.97M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 8.24M | 6.78M |
| Income Tax | 944.76K | 481.94K |
| Net Income | 7.30M | 6.30M |
| EPS Basic | - | 0.315043 |
| EPS Diluted | - | 0.315043 |
| Basic Shares Outstanding | - | 20M |
| Diluted Shares Outstanding | - | 20M |
| Ebit | 9.02M | 7.12M |
| Ebitda | 9.02M | 7.12M |
| Net Income Continuous Operations | - | - |
| Minority Interests | - | - |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
